Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
Condition: Chronic Obstructive Pulmonary Disease (COPD) Interventions: Drug: Placebo; Drug: Tozorakimab Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials